Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tricida had an Agreement to buy Veverimer from Patheon, but since it doesn't work worth a damn that's the end of the Agreement.
How about a little more detail on this material breach which Patheon is cancelling anyway
Averaged down, just in case they find a buyer. BOD hasn't sold out so some hope.
It had a very nice pop Monday but it gave almost all of it back already.
If it drops into the teens I think it goes to a nickel or to pinks at a penny. I have seen no indication that they plan to continue in business.
said looking fer buyer or suitor $TCDA
yes EB just seeing TCDA 1st time. i like dis one, ah little cheaper
teens
But on Nov 25th two 10% holders LIQUIDATED 100% OUT OF THEIR POSITIONS.
Recent TCDA News
Needham Sticks to Its Hold Rating for Tricida (TCDA) • TipRanks • 11/15/2022 10:25:06 AM
TCDA
Tricida Inc
0.2416
0.0016 (0.67%)
Volume: 3,855,768
Day Range: 0.23 - 0.25
Last Trade Time: 12:03:02 PM EST
YOU SURE ????? TCDA ????? Market Cap 15 m. Cash 80 m. A buyer will come.
GOT AH LINK ?????
It's worth the small risk at this point. Averaging a loser down in the hope of sunshine.
No doubt. I believe we will make lots of money here.
Market Cap 15 m. Cash 80 m. A buyer will come.
TCDA- it’s coming very soon. https://www.businesswire.com/news/home/20221102006072/en/
TENX is in the same financial situation as TCDA Tricida Inc. Even almost the same amount of outstanding shares. The big diferents is that TENX has it's two drugs with excellent results ready for phase 3. I can see TENX going extremely high any day
Where did you get your finance degree? Did you not learn anything at all? Is facebook, Amazon, twitter, Tesla, Walmart filled for bankruptcy? You don’t know anything about business, but yet you are here talking trash.
TCDA $$$ $10.00+...WE COULD SEE IT AGAIN...SHORTS ARE IN TROUBLE...WATCH TOMORROW..
Bankruptcy, Tricida to lay off ~60% of employees following strategic review announcement.
https://seekingalpha.com/news/3908658-tricida-to-lay-off-60-of-employees-following-strategic-review-announcement?utm_source=otcmarkets&utm_medium=referral
Like all the bankruptcy companies did before filing bankruptcy.
It’s finished! Going to file bankruptcy shortly.
I hope all of you get in line with the program because TCDA will not stop for anything.
Company research experience, even though a failure, has value for other companies to buy.
The stock was over sold. It has a big short position… and the company is looking for a buyer
But it crashed epic because the fail of their study. So why should it jump or fill some GAP
This is about short covering not a catalyst. Huge gap to fill.
Agreed. Massive upside potential. Massive short amount. Huge gap at .80 - $10
This one will go ballistic very soon. I hate to say I told you so.
Hi, any possible upcoming catalyst here? I see there is a big gap to fill in the chart.
Orbimed Advisors, LLC and Directors liquidated all their common shares. Form 4 filed Nov. 25, 2022.
Click on Ownership Disclosures -- https://www.sec.gov/edgar/browse/?CIK=1595585&owner=exclude
>>> Move on to ELTP before a monster run.
Orbimed Advisors, LLC and Directors liquidated all their common shares. Form 4 filed Nov. 25, 2022.
https://www.sec.gov/edgar/browse/?CIK=1595585&owner=exclude
>>> Move on to ELTP before a monster run.
TCDA, from $12.5 to $0.2? What’s happened?
Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.
-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings
Outstanding Shares: 1.01 Billion
Float : ~ 750 Million
Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm
ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall
>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.
Good little move. Watch.
TCDA
Premarket volume. PPS up. Big bounce?
TCDA
End of September $80 million cash or cash equivalent.
Now what? New testing variant?
~ $TCDA ~ Hollow red candle developing on the daily chart. Always buy on hollow reds.
~ $TCDA ~ Loaded the boat. Easy 10x from this level. IMO #Beingfirstmatters
How big is the gap on $TCDA please?
$TCDA RSI at 19 and MACD flip incoming..could see a nice move from here…
https://stockcharts.com/c-sc/sc?s=TCDA&p=D&b=5&g=0&i=0&r=1668259052937
$TCDA Gap fill of the ages here..just might have found bottom Friday..close eye on this one next week..
https://stockcharts.com/c-sc/sc?s=TCDA&p=D&b=5&g=0&i=0&r=1667651249111
Does an earnings report even matter at this point?
Have they reported earnings already? If not, when?
Followers
|
4
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
141
|
Created
|
07/17/20
|
Type
|
Free
|
Moderators |
7000 Shoreline Court
Suite 201
South San Francisco, CA 94080
(415) 429-7800
About Tricida
Tricida, Inc. is a pharmaceutical company focused on the development of its investigational drug candidate, veverimer,
a non-absorbed, orally-administered polymer designed to slow CKD progression in patients with metabolic acidosis and CKD.
Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration.
It is estimated to pose a health risk to approximately 4.3 million patients with CKD in the United States.
There are currently no therapies approved by the FDA to slow progression of kidney disease through
the treatment of chronic metabolic acidosis in patients with CKD.
For more information about Tricida, please visit http://Tricida.com.
https://seekingalpha.com/symbol/VPER
https://www.otcmarkets.com/stock/VPER
FORM TYPE | RECEIVED | PERIOD END DATE | REPORT |
---|---|---|---|
4 | 11/25/2022 | 11/22/2022 | PDFRTFHTMLXLS |
4 | 11/25/2022 | 11/22/2022 | PDFRTFHTMLXLShttps://investorshub.advfn.com/boards/read_msg.aspx?message_id=170583079 |
SC 13D/A | 11/25/2022 | PDFRTFHTMLXLS | |
4 | 11/25/2022 | 11/23/2022 | PDFRTFHTMLXLS |
4 | 11/22/2022 | 11/21/2022 | PDFRTFHTMLXLS |
8-K | 11/17/2022 | 11/15/2022 | PDFRTFHTMLXLS |
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*DISCLAIMER *The Board Monitor and herewith, are not licensed brokers and assume NO responsibility for the actions,
investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |